Publication | Open Access

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Italian Multicentre StudyUrologyGenitourinary CancerMedicineOther Second-line TreatmentOutcomes ResearchClinical OutcomesPharmacotherapyProstatic DiseaseOncologyRadiation OncologyHealth Sciences